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Abstract
This review focuses on the contribution of abnormal blood rheology in the pathophysiology
of sickle cell anemia (SCA). SCA is characterized by a reduction of red blood cell (RBC)
deformability but this reduction is very heterogeneous from one patient to another. Recent
works have shown that patients with the lowest RBC deformability (measured by
ektacytometry) have enhanced hemolysis and would be more prone to develop several
complications such as priapism, leg ulcers and glomerulopathy. In contrast, patients with the
highest deformability, and not under hydroxyurea therapy, seem to develop more frequently
vaso-occlusive like events. Although less studied, RBC aggregation properties are very
different between SCA and healthy individuals and it was demonstrated that increased RBC
aggregates strength could be involved in some complications. Finally, several works
demonstrated that the vascular system of SCA patients could not fully compensate any
increase in blood viscosity because of the loss of vascular reactivity, which may result in
vaso-occlusive crises.

Key words: sickle cell anemia, blood viscosity, red blood cell deformability, red blood cell
aggregation
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1. Introduction
Sickle cell anemia (SCA) is the most frequent genetic disease in the world. It is characterized
by a single nucleotide mutation (adenine → thymine) in exon I of the -globin gene that leads
to the presence of sickle hemoglobin (HbS) resulting from the substitution of valine for
glutamic acid at the sixth position of the β-globin chain. When deoxygenated, HbS is able to
polymerize, hence causing a mechanical distortion of red blood cells (RBCs): i.e., sickling.
Sickle RBCs are rigid and do not easily flow through the microcirculation, causing frequent
vaso-occlusive episodes in affected patients. Recurrent HbS polymerization leads to
numerous RBC and systemic physiological abnormalities with variable phenotypic
severity.{Embury, 1986 #2} In addition, sickle RBCs are very fragile, which may explain
why patients are chronically anemic.

2. RBC deformability in SCA
Mean RBC deformability (measured by ektacytometry) is decreased in SCA patients at steady
state compared to healthy individuals (Ballas et al, 1988; Messmann et al, 1990; Tripette et al,
2009). The proportion of dehydrated irreversible sickle RBCs (ISCs) in the blood of the
patients impact directly on the mean deformability of the whole RBC suspension (Ballas et al,
1992). Both RBC membrane stiffening and increased internal viscosity are responsible for the
lowering of RBC deformability (Chien et al, 1970; Li et al, 2017). Deoxygenation of HbS, as
it may occur in post-capillary venules, further causes a reduction in RBC deformability
because the formation of polymerized HbS fibers disrupts cell morphology (Chien et al,
1970). When re-oxygenated, most of the sickled RBCs unsickle and recover their
deformability, although still reduced compared to healthy RBCs.

2-1. Reduced RBC deformability, increased hemolysis and endothelial dysfunction:
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RBC deformability has been extensively studied in the context of SCA. It appears that
patients with leg ulcers (Connes et al, 2013; Bowers et al, 2016), frequent priapism (Cita et al,
2016) or glomerulopathy (Lamarre et al, 2014) have lower RBC deformability than patients
without these complications. These findings are in agreement with those of Bartollucci et al
(2012) who reported higher number of dense RBCs in patients with leg ulcers, renal
dysfunction and priapism. Interestingly, these complications belong to the so-called
hemolytic-endothelial dysfunction phenotype (Kato et al, 2007) and we recently reported a
negative association between RBC deformability and several markers of hemolysis (Connes
et al, 2014). Indeed, patients with a severe reduction in RBC deformability would be
characterized by increased hemolytic rate and marked anemia (Connes et al, 2014).
Nevertheless, further works are needed to investigate the mechanisms that link reduced RBC
deformability and increased RBC fragility in SCA. It is now admitted that hemolysis plays a
key role in the pathophysiology of SCA (Kato et al, 2007). Part of the free hemoglobin
released into plasma quickly reacts with haptoglobin and the complex is cleared from plasma.
However, this system is insufficient to eliminate the excess of free circulating hemoglobin in
SCA and a large amount reacts with nitric oxide (NO) to produce methemoglobin and nitrate
ultimately leading to reduced NO bioavailability.{Kato, 2007 #35} The release of RBC
arginase into the plasma catabolizes plasma arginine reducing its bioavailability. In addition,
heme and heme-iron dissociate from Hb catalyzing the production of reactive oxygen species
(ROS) that serve as potent NO scavengers.{Kato, 2007 #35} The decline in blood NO
content leads to endothelial dysfunction, over-expression of vascular adhesion molecules and
impaired vasomotor tone (Kato et al, 2005; Lin et al, 2005; Moeckesch et al, 2017). In support
of these mechanisms, plasma from patients with SCA contains cell-free ferrous
oxyhemoglobin, which stoichiometrically consumes micromolar quantities of NO and
abrogates forearm blood flow response to NO donor infusion.{Reiter, 2002 #41} In
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summary, it seems that a direct link exists between reduced RBC deformability, increased
hemolysis and the development of chronic vasculopathy in SCA (Connes et al, 2016).

2-2. RBC deformability and vaso-occlusive events:
In contrast, it has been demonstrated that although an increase of RBC deformability is
beneficial for blood flow (because of the reduction of blood viscosity for instance) and tissue
perfusion (because deformable RBC can easily negotiate small capillaries) in the healthy
population, SCA patients with the highest RBC deformability would be prone to
osteonecrosis {Lemonne, 2013 #60} and frequent acute painful vaso-occlusive crises
(VOC).{Lamarre, 2012 #53;Lande, 1988 #51} The increased risk of SCA patients with
alpha-thalassemia to develop frequent VOC compared to those without has been attributed to
the effects of alpha-thalassemia on RBC deformability (Renoux et al, 2017). While RBC
deformability is decreased during vaso-occlusive events, Ballas et al.{Ballas, 1992 #22}
demonstrated that high level of RBC deformability during the recovery phase of a painful
vaso-occlusive event was a predictor of a new painful crisis. Lande et al.{Lande, 1988 #51}
also reported a significant and positive correlation between the incidence of painful crisis in
SCA and RBC deformability, a result initially reported by Ballas et al.{Ballas, 1991
#62;Ballas, 1988 #61} This surprising finding may be explained by the fact that sickle RBCs
with the highest deformability are also the most adherent RBCs to the vascular wall, thus
decreasing the lumen of microvessels, slowing blood flow and initiating vascular
occlusion.{Ballas, 1988 #61;Kaul, 2004 #64;Mohandas, 1989 #63} The increased
adhesiveness of sickle RBCs with the highest deformability would be explained by the fact
that they could spread their adhesive patch to a greater extent than the more rigid sickle RBCs
(Mohandas et al, 1989). In contrast, although hydroxyurea therapy improves RBC
deformability in SCA patients, it also decreases the frequency of VOC-like events (Lemonne
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et al, 2015; In press) because it also decreases the ability of sickle RBCs to adhere to the
endothelium (Ware et al, 2010). The deformability of RBCs in SCA is influenced by several
factors such as the amount of fetal hemoglobin (HbF, Lemonne et al, 2015; Renoux et al,
2016), the magnitude of oxidative stress (Hierso et al, 2014) and the level of nitric oxide
(Mozar et al, 2016; Wajih et al, 2017).

3. RBC aggregation in SCA
RBC aggregation properties have been poorly studied in SCA but several studies reported that
RBC aggregation (which depends on the number of RBC aggregates and time for RBC
aggregates formation) is rather decreased in SCA patients compared to healthy individuals.
The lower RBC aggregation seems to be due to the low ability of the rigid ISCs to form
aggregates.{Chien, 1970 #8;Connes, 2014 #21} Deoxygenating sickle cell blood in vitro
results in a further decrease of RBC deformability and RBC aggregation.{Bucherer, 1992
#110} However, patients with increased RBC aggregation seems to be prone to frequent
VOC-like events (Lemonne et al, 2012; Renoux et al, 2017). While RBC aggregation is rather
decreased in SCA, once formed, sickle RBC aggregates are 2 to 3 fold more robust than
healthy RBC aggregates.{Tripette, 2009 #15;Waltz, 2012 #20} Chronic enhanced oxidative
stress has been reported to strongly modulate the strength of RBC aggregates (Hierso et al,
2014). The findings of Loiseau et al (2015) suggest that these sticky RBC aggregates would
preferentially deposit at bifurcation level in vascular network, which could increase the risks
for vaso-occlusive like events. Indeed, Lamarre et al (2012) found an association between
RBC aggregates strength and acute chest syndrome in SCA. No study to date measured the
changes in RBC aggregation during a vaso-occlusive event in SCA and only limited data is
available on erythrocyte sedimentation rate, a parameter that is affected by both hematocrit
and RBC aggregation.{Lawrence, 1986 #30}, {Awodu, 2009 #31} The increase of
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fibrinogen during VOC could promote RBC aggregation{Awodu, 2009 #31} but further
studies are needed to directly investigate this parameter during crisis.

4. Blood viscosity in SCA
Owing to the chronic severe anemia, patients with SCA have lower blood viscosity at native
hematocrit under oxygenated conditions than individuals with normal hemoglobin.{Tripette,
2009 #15} However, blood viscosity increases with ageing in SCA patients (Renoux et al,
2015), which could explain why osteonecrosis and retinopathy prevalence increase with age
in this population {Lemonne, 2014 #9;Serjeant, 1995 #26}. When adjusted to a normal
hematocrit levels (40-45%), SCA patients have blood viscosity that is above the controls
under oxygenated conditions (partly due to the presence of ISCs). When deoxygenated, the
sickling of RBCs causes a further rise in blood viscosity at all shear rates.{Chien, 1970 #8}
Classically, it is suspected that any increase in blood viscosity could be deleterious for the
cardiovascular system. However, a rise in blood viscosity is pretty well tolerated in the
general population (Salazar-Vazquez et al, 2008). The production of NO by the endothelial
NO-synthase is strongly dependent on the shear stress applied on the vascular wall. Shear
stress is the product of shear rate by blood viscosity. Indeed, when blood viscosity increases,
endothelial cells produce more NO, which results in compensatory vasodilation that
normalizes vascular resistance and blood flow (Tsai et al, 2005; Connes et al, 2013).
However, in case of endothelial/vascular dysfunction, like in SCA (Kato et al, 2007; Charlot
et al, 2016; Ranque et al, 2016; Ataga et al, 2016; Moeckesh et al, 2017), a rise in blood
viscosity could not be fully compensated and is suspected to impair blood flow (Kato et al,
2007).
A large epidemiological study in the United States (the Cooperative Study of Sickle Cell
Disease) demonstrated that high hematocrit and Hb increased the risks for VOC {Platt, 1991
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#49} and acute chest syndrome,{Castro, 1994 #50} respectively, in SCA. This is in
agreement with previous findings showing that Hb value is an independent predictor for the
development of acute pain crisis in SCA.{Lande, 1988 #51} Hematocrit is a key determinant
of blood viscosity, particularly at low shear rate where the rise in viscosity is exponential.
Indeed, it is not surprising to observe that SCA patients with more frequent hospital
admissions for VOC have higher blood viscosity at steady state than patients with less
frequent hospitalizations (Nebor et al, 2011; Lamarre et al, 2012; Renoux et al, 2017).
Moreover, blood viscosity was shown to rise further during a vaso-occlusive episode, which
may worsen tissue perfusion and oxygenation.{Awodu, 2009 #31}

5. Conclusion
Progress has been made in the last decades in the understanding of the pathophysiological
mechanisms involved in SCA. Previous and recent studies identified several potential
biomarkers and hemorheological predictors of various acute and chronic complications that
paved the way for stimulating novel approaches to develop appropriate therapies. In addition,
further studies are needed to better understand the relationships between RBC rheological
properties, RBC fragility (i.e., hemolysis) and RBC adhesiveness in the context of SCA.
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